![Frailty and polypharmacy in elderly patients are associated with a high readmission risk | Request PDF Frailty and polypharmacy in elderly patients are associated with a high readmission risk | Request PDF](https://www.researchgate.net/publication/341758582/figure/fig1/AS:1136981723615233@1648088975767/figure-fig1_Q320.jpg)
Frailty and polypharmacy in elderly patients are associated with a high readmission risk | Request PDF
![Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes | Future Science OA Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes | Future Science OA](https://www.future-science.com/cms/10.2144/fsoa-2020-0039/asset/images/medium/figure3.gif)
Patterns and characteristics of polypharmacy among elderly residents in Danish nursing homes | Future Science OA
![Lægedage Den Ældre Patient – Pause. Lægedage Case Benny har for 2 dage siden oplevet besvær med at bruge højre hånd og let talebesvær. Han. - ppt download Lægedage Den Ældre Patient – Pause. Lægedage Case Benny har for 2 dage siden oplevet besvær med at bruge højre hånd og let talebesvær. Han. - ppt download](https://images.slideplayer.dk/40/11124454/slides/slide_9.jpg)
Lægedage Den Ældre Patient – Pause. Lægedage Case Benny har for 2 dage siden oplevet besvær med at bruge højre hånd og let talebesvær. Han. - ppt download
![PDF) Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect PDF) Cabozantinib, Vandetanib, Pralsetinib and Selpercatinib as Treatment for Progressed Medullary Thyroid Cancer with a Main Focus on Hypertension as Adverse Effect](https://i1.rgstatic.net/publication/367445681_Cabozantinib_Vandetanib_Pralsetinib_and_Selpercatinib_as_Treatment_for_Progressed_Medullary_Thyroid_Cancer_with_a_Main_Focus_on_Hypertension_as_Adverse_Effect/links/63d27e76e922c50e99c670c1/largepreview.png)